CINPHA — Cinclus Pharma Holding publ AB Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Cinclus Pharma Holding publ AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39.3 | -84.3 | -213 | -201 | -170 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0 | 2.51 | -4.32 | -4.82 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.196 | 8.85 | 16.9 | -5.15 | -5.25 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -39.5 | -75.4 | -192 | -209 | -178 |
| Capital Expenditures | 0 | -0.131 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.065 | 0 | 0 | 0 | — |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.065 | -0.131 | 0 | 0 | — |
| Financing Cash Flow Items | -16.5 | -0.128 | -15.4 | -0.167 | -58.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 233 | 4.95 | 226 | 123 | 655 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 195 | -70.3 | 35.3 | -85.6 | 479 |